Business Description
Spruce Biosciences is a drug development company working on treatments for rare and serious medical conditions, including Sanfilippo Syndrome Type B, depression, and Congenital Adrenal Hyperplasia. Its leading programs include an enzyme-based therapy, an antidepressant compound, and a treatment for a rare hormonal disorder that currently has no cure. The company holds partnerships with Eli Lilly and Kaken Pharmaceutical to support research and bring its drugs to market in the United States and Japan. Founded in 2014, Spruce Biosciences operates out of South San Francisco, California.
